The recent Hantavirus outbreak on a cruise ship has raised concerns about a potential new pandemic, but experts argue that the 'Andes virus' is fundamentally different from COVID-19 and won't cause the next global health crisis. While the virus is serious and requires cautious response, it lacks the key characteristics that made SARS-CoV-2 a pandemic threat.
One of the main differences is transmission. Hantaviruses, including the Andes virus, primarily spread through contact with contaminated rodent urine, droppings, or saliva, and person-to-person transmission is rare. This contrasts sharply with COVID-19, which spreads efficiently through the air, allowing people to infect others before they even know they're sick. The Andes virus requires a specific set of conditions for human-to-human transmission, such as symptomatic individuals in crowded, poorly ventilated spaces with prolonged close contact, which was the case on the MV Hondius.
Symptoms of the Andes virus can mimic other illnesses, including fever, headache, muscle aches, nausea, and fatigue. In some cases, it can progress to hantavirus pulmonary syndrome, a life-threatening condition causing breathing difficulties. The incubation period is much longer than for COVID-19, with the WHO recommending monitoring for symptoms for 42 days after exposure. This extended period reflects the virus's slower progression and the need for careful monitoring.
The Andes virus's fatality rate is concerning, with up to 50% of cases leading to hantavirus pulmonary syndrome. However, it's important to note that severe infections remain rare. In 2025, eight countries in the Americas reported 229 cases and 59 deaths, highlighting the virus's severity but also its limited spread.
Treatment for the Andes virus is currently limited to supportive care, monitoring, and managing complications. There is no specific antiviral drug or licensed vaccine. However, the scientific community's rapid response to the outbreak, including the quick sequencing and public availability of the virus's genetic code, demonstrates a commitment to understanding and combating the virus.
In conclusion, while the Andes virus is a serious health concern, it is not a pandemic threat like COVID-19. Its slower incubation, limited human-to-human transmission, and rare but severe cases make it distinct from the highly contagious and rapidly spreading SARS-CoV-2. The outbreak serves as a reminder of the importance of understanding and managing viral threats, but it also highlights the differences that make some viruses more concerning than others.
